Drug-decreased percentage of Ki67high cells indicates reduced proliferation rate, whereas increased percentages of nerve growth factor receptor (CD271)high cells suggest selection of melanoma stem-like cells by vemurafenib and trametinib [17]. This evidence concerns the gene NGFR and melanoma.